At Clark Health, we are always looking for the next “big thing” in healthcare. With several neuroscience graduates in our team and our broad experience working on neurology products, it’s an area we like to keep an eye on. Like many other disease areas, breakthroughs in the world of neuroscience are incredibly rare, so when a Huntington’s disease treatment made new ground earlier this year1, it created waves of excitement and we’ve been watching this space ever since. Read more
Recently, there have been a number of reports and studies exploring the potential therapeutic applications of currently illicit drugs. Cannabis is breaking down barriers in the treatment of certain types of epilepsy in the UK and a marketing application for an intranasal esketamine spray has been submitted to the EMA for treatment-resistant major depressive disorder.
Currently available antidepressants, such as SSRIs, are used collectively to treat major depressive disorder, anxiety and other mood disorders. They have been shown to lack substantial efficacy in all patient populations and are renowned for having a delayed onset of action (Penn and Tracy, 2012). Working in the area of mental health at CHC, coupled with an interest to find out more, we ventured further into a current avenue of research that looked more and more curious…
We’ve been talking a lot about Delivering ChangeTM as of late, and one of the key components of the Delivering ChangeTM process is to seek external sources of inspiration to help drive unexpected creative approaches in our work. With that in mind, three of the team wandered over to the ExCel London for The New Scientist Live 2018. This year, in particular, we were impressed by the various methods of communication. Read on for some of our highlights:
On 1st August we launched our new Delivering ChangeTM planning model and in this short blog we wanted to outline the two key reasons why.
- We’re serious about focusing our work around real, measurable change for our clients and for healthcare professional and patients around the world.
We’ve talked about Delivering Change as part of the CHC brand for a couple of years now and even before that, it was a founding principle of the company.
Those of you who are familiar with CHC might recognise our core values of Building Collaboration, Inspiring Confidence and Delivering Change. After over a year’s worth of valuable qualitative and quantitative research into the ever-evolving needs of those working in pharmaceutical marketing, medical and communications functions, we are thrilled to be launching our new Delivering ChangeTM planning model.
This Friday 10th November is World Science Day for Peace and Development. On this day, a number of events across the world aim to engage people in scientific discussion through innovative and creative communication. This reminds us of an event CHC recently attended at the ExCel Centre in London, the New Scientist Live.
Ahead of an exciting new period of team growth we took five minutes to quiz our most recent graduate recruit.
The CHC offices are full of people who have a real passion for science, so it’s important to us that we maintain our curiosity and stay informed. That’s why the CHC team found themselves faced with a 28ft giant inflatable E.coli as we ventured along to two days of New Scientist Live, taking place at the ExCel London.
The hall was split into four themed zones: Technology, Brain & Body, Cosmos and Earth, with each section hosting a number of exhibits and talks. Some of our highlights included:
The future of healthcare –Ruth McKernan of Innovate UK